← All trials
NCT04988425
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2021
- Primary completion
- Aug 30, 2023
- Completion date
- Aug 30, 2023
- First posted
- Aug 3, 2021
- Last posted
- Aug 3, 2021
- Enrollment
- 90
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Second Military Medical UniversityLead sponsor
- Second Military Medical UniversityOverall official - principal investigator
- Second Military Medical UniversityReponsible party - principal investigator
- Zhenjiang TCM HospitalCollaborator
- Wuxi 904 HospitalCollaborator
- Nanjing Medical UniversityCollaborator
- Kunshan TCM HospitalCollaborator
- Sixth People's Hospital of NantongCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.